Front. Immunol.
Frontiers in Immunology
Front. Immunol.
1664-3224
Frontiers Media S.A.
10.3389/fimmu.2024.1494021
Immunology
Erratum
Erratum: First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)
Frontiers Production Office
*
Frontiers Media SA, Lausanne, Switzerland
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
19
09
2024
2024
15
1494021
10
09
2024
10
09
2024
Copyright © 2024 Frontiers Production Office
2024
Frontiers Production Office
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
An erratum on First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax) By Ridolfi L, Gurrieri L, Riva N, Bulgarelli J, De Rosa F, Guidoboni M, Fausti V, Ranallo N, Calpona S, Tazzari M, Petrini M, Granato AM, Pancisi E, Foca F, Dall’Agata M, Bondi I, Amadori E, Cortesi P, Zani C, Ancarani V, Gamboni A, Polselli A, Pasini G, Bartolini D, Maimone G, Arpa D and Tosatto L (2024). Front. Immunol. 15:1404861. doi: 10.3389/fimmu.2024.1404861
glioblastoma
vaccine
immunotherapy
dendritic cell
adoptive cell therapy
radiochemotherapy
section-in-acceptance
Cancer Immunity and Immunotherapy
Due to a production error, an author name was incorrectly spelled as “Monia D’Allagata”. The correct spelling is “Monia Dall’Agata”.
The publisher apologizes for this mistake.
The original version of this article has been updated.